Wednesday 23 July 2014

Lyophilization For Pharmaceuticals Market Equipment And Services 2013 - 2019

Lyophilization also called as freeze drying is a process of dehydration of samples, commonly used to preserve perishable substances. In pharmaceutical industries, it is used to concentrate and stabilize products into powder form. The process consists of four stages- lyophilization pretreatment, freezing the compound, primary drying process, secondary drying. Pretreating the products includes concentrating the product and formulation to increase the surface area. Once the product is pretreated, it is frozen using methanol or liquid nitrogen. At this stage, the compound is cooled below its triple point which is the lowest temperature at which the vapor, liquid and solid state co-exist. In the next stage of primary drying, the pressure is reduced so that water in the compound sublimates. In the last stage, the unfrozen water molecules are removed by increasing the temperature to near 0 degrees and lowering pressure for desorption.


Lyophilization is an effective preservation process and stabilization of compounds such as proteins, peptides, vaccines, blood fractions, enzymes, microbes, nutraceuticals and other biopharmaceutical products. They help in extending the shelf life while maintaining the functionality and integrity of the biomolecules. Due to reduction of storage space and weight, they also make the handling easier and avoid the need of cold storage.

Lyophilization market can be segmented based on product type as follows:

Lyophilization units
  • Manifold freeze dryer
  • Rotary freeze dryer
  • Tray style freeze dryer
Lyophilization services

The lyophilization market will be driven by its wide scope of application, the advances in the pharmaceutical industry such as new drug discovery and technological advances in the lyophilization methods such as computer controlled process and automation in loading and unloading by robotics. These augmentations will make the overall process easier and will help in expanding the scope of application. The lyophilization instruments are expensive and high electricity consumption unit. Apart from these factors the process time for lyophilization is also long. But considering the merits, the restraints do not drastically affect the market growth.

Some of the key players in the lyophilization units market are ABB Ltd., W.L. Gore & Associates, Inc. and GEA Niro while Lyophilization Technology, Inc., GenScript, Inc. Irvine Pharmaceutical Services are some of the pyophilization services providers.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
  • North America 
  • Asia Pacific 
  • Europe
  • Rest of the World  
This report provides comprehensive analysis of
  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for upcoming years 
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.


About us 

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.




Contact Us 

Sheela AK
Corporate Office:
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States.

Tel: +1-518-618-1030

Browse Market Research Blogs: 
Posted by at No comments:
Labels: , , ,
Location: Albany, NY, USA

Tuesday 22 July 2014

Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2012 - 2018

Pills
Methicillin-resistant staphylococcus aureus (MRSA) infections are caused due to Staphylococcus aureus bacterium which infects different parts of the body. These infections are difficult to treat due to high degree of resistance of these pathogens to the most commonly used antibiotics such as methicillin, amoxicillin, penicillin and oxacillin. The bacterium infects different parts of the body namely, skin, surgical wounds, blood streams, lungs, IV or other sites where the tubes such as catheters enter the body or the urinary tract and cause infection which can be life threatening.

MRSA infection is known to spread by casual contact or through contaminated objects called community associated MRSA (CA MRSA). It may also be acquired in hospitals or health care settings - healthcare associated MRSA (HA MRSA) which is the most common form of MRSA infection. Community associated methicillin resistant S. aureus (CA-MRSA) infections are different from healthcare associated methicillin resistant S. aureus (HA-MRSA) considering their epidemiology and the characteristics of the strains which causes the infection. Overuse of antibiotics and use of potent drugs for less serious infections may also cause development of MRSA. The symptoms of infection depend on the site of infection and it can be diagnosed by laboratory testing.

One of the major drivers contributing to the market growth for MRSA drugs is increase in the prevalence of MRSA infections. In addition, growth in the government and non-government awareness programs has also become a key factor in improving the market growth. However, overcoming the tendency of pathogen for developing resistance to multi-drugs and increase in competition between the generic market players could impose a challenge to the market growth.

MRSA can be usually treated by antibiotics such as bactrim and vancomycin though the pathogen has started developing resistance for these drugs too owing to its constant adapting power to newly developed antibiotics. Other options for the treatment of MRSA infection are generics such as clindamycin and minocycline, and prime brand-names such as Tygacil, Cubicin, Zyvox, and Synercid. Some of these antibiotics are only available intravenously. The most effective way of controlling the spread of MRSA is practicing basic hygiene such as use of disposable gloves, washing hands before making direct contact with patients as well as proper wound care.

Geographically, North America leads this market and is followed by Europe. However, increase in the development of healthcare infrastructure in emerging economies forecasts growth in demand for MRSA drugs in Asia-Pacific and other parts of the world. Some of the major players in this market include Takeda Pharmaceutical Company Limited, Merck & Co., Inc, AstraZeneca PLC, GlaxoSmithKline PLC, Pfizer, Inc., Cubist Pharmaceuticals, Inc., ViroPharma, Inc., Forest Laboratories, Inc., and Theravance, Inc.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
  • North America
  • Asia Pacific
  • Europe
  • Rest of the World
This report provides comprehensive analysis of
  • Market growth drivers
  • Factors limiting market growth
  • Current market trends
  • Market structure
  • Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

About us
Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Contact Us
Sheela AK
Corporate Office:
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States.
Tel: +1-518-618-1030
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

Posted by at No comments:
Labels: , , , ,

Monday 7 July 2014

Global Research on Medical Image Processing Market - Industry Analysis 2014-2020

Medical Image Processing Market
Medical imaging refers to the visualization of the body parts, organs, tissues or cells for clinical diagnosis, disease monitoring and treatment. The imaging techniques used in medical devices include variety of modern equipments in the field of optical imaging, nuclear imaging, radiology and other image-guided intervention. The radiological method renders anatomical and physiological of the human body at a very high spatial and temporal resolution. The radiology discipline covers methods such as ultrasound, CT scan, X-ray, MRI and other similar devices. Whereas, the optical imaging techniques include devices such as optical coherence tomography (OCT), which helps in revealing abnormalities at cellular level with the help of optical tracers for specific tumor cells.
OCT techniques are yet at early stages of development and are likely to uplift the medical imaging market in coming years. Nuclear imaging techniques such as PET and SPECT display remarkable details with respect to metabolism, physiology and molecular function. The major post processing work include activities such as, image reconstruction, image processing, 3D view generation, computer-aided detection, and quality control.
With the increasing development in medical research produces a continuous stream of knowledge about disease processes or stages, new therapeutic targets and complex relationship between a person’s genome and his and her related risk for diseases. Medical imaging can now play a central and vital role in global healthcare systems as it continues to improve patient outcomes and cost effective healthcare diagnostic for almost all disease and deformity class. Traditionally, medical imaging was considered as a tool for non-invasive mapping for recognition and localization of disease process. 
Owing to technological advancements, a wide variety of new medical imaging techniques and methods produce important biological information about molecular biology, physiology, biochemistry, organ function, metabolism, and functional genomics. Furthermore, the medical imaging which many think are only used in diagnostic procedures are now even used for treatment processes such as coronary angioplasty which is used for treating aortic aneurysm and stoppage of cerebral aneurysm bleedings.
Some of the major drivers for the medical imaging processes include miniaturization or portability of devices such as X-Rays, ultrasound devices which come in handheld device forms that enhance the reach and optimization of devices to rural, disaster sites, and even in ambulances which eventually save time for both patients as well as the physicians in case of emergencies. 3D imaging techniques are another opportunity area in the medical image processing market. However, such technically sophisticated devices are confined majorly to the developed economic regions due to lack of pooper budget allocation from government and regulatory bodies.
The major restraints to the global medical image processing market include intense competition from local, lack of skilled radiologists especially in the emerging market and developing market and lack of proper medical reimbursement scenario. Despite such issue, the emerging economies are likely to be the fastest growing markets in the coming years due to substantial public and private investments in development of healthcare infrastructure and rise in disposable income among the middle class population.
Some of the prominent players in the global medical image processing market include Siemens Healthcare, Philips Healthcare, GE Healthcare, Toshiba Medical Systems Corp., Toshiba America Medical Systems, Rcadia Medical Imaging Ltd., TomTec Imaging Systems GmbH, Calgary Scientific Inc., Riverain Medical Group LLC among others.
This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
  • North America
  • Asia Pacific
  • Europe
  • Rest of the World
This report provides comprehensive analysis of
  • Market growth drivers
  • Factors limiting market growth
  • Current market trends
  • Market structure
  • Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
About us
Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.
TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.
Contact Us
Sheela AK
Corporate Office:
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States.
Posted by at No comments:
Labels: , , ,
Location: Albany, NY, USA
Subscribe to: Posts (Atom)